EMEA-001072-PIP01-10-M02

Key facts

Invented name
Lemtrada
Active substance
alemtuzumab
Therapeutic area
Neurology
Decision number
P/0170/2016
PIP number
EMEA-001072-PIP01-10-M02
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of multiple sclerosis
Route(s) of administration
Intravenous use
Contact for public enquiries
Genzyme Europe B.V.
The Netherlands
Tel: +49 (0) 800 52 52 010
E-mail: medinfo.de@sanofi.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating